These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3917983)

  • 21. Evaluation of an antiallergic agent (disodium cromoglycate) in rat conjunctiva using monoclonal IgE antibody.
    Tanaka H; Umemoto M; Miichi H; Hayashi S
    Ophthalmic Res; 1987; 19(4):240-4. PubMed ID: 3122141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of homologous passive cutaneous anaphylaxis (PCA) by disodium cromoglycate-related compounds.
    Koda A; Sakamoto K; Yanagihara Y
    Jpn J Pharmacol; 1980 Aug; 30(4):437-47. PubMed ID: 6162986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (2-Carboxy-1,4-dihydro-4-oxoquinolyl)oxamic acids and (2-carboxy-1,4-dihydro-4-oxobenzo[h]quinolyl)oxamic acids as antiallergy agents.
    Wright JB; Johnson HG
    J Med Chem; 1977 Jan; 20(1):166-9. PubMed ID: 833818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRL 22321. A compound with similarities to both disodium cromoglycate and theophylline.
    Smith H; Ross JW; Spicer BA; Clarke GD; Harling EJ; Hassall PA; Taylor JF
    Monogr Allergy; 1983; 18():223-5. PubMed ID: 6196629
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats.
    De Vos C; Dessy F; Hermecz I; Meszaros Z; Breining T
    Int Arch Allergy Appl Immunol; 1982; 67(4):362-8. PubMed ID: 6175586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of sulfur dioxide-induced airways hyperresponsiveness in the conscious dog.
    Lewis AJ; Kirchner T
    Int Arch Allergy Appl Immunol; 1984; 75(2):188-90. PubMed ID: 6432705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased vascular permeability during passive peritoneal anaphylaxis in the rat. The effects of disodium cromoglycate and a nitroindanedione.
    Ross JW; Smith H; Spicer BA
    Int Arch Allergy Appl Immunol; 1976; 51(2):226-37. PubMed ID: 58838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs.
    Yanagihara Y; Kasai H; Kawashima T; Shida T
    Jpn J Pharmacol; 1988 Sep; 48(1):91-101. PubMed ID: 2462074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of passive lung anaphylaxis in the rat by AY-25,674.
    Greenberg R; Martel RR; Smorong K
    Can J Physiol Pharmacol; 1979 Jan; 57(1):48-52. PubMed ID: 106941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopharmacologic properties of WY-16,922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Apr; 197(1):153-62. PubMed ID: 57234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The difference in effect of predosing with antiallergic compounds between the rat PCA model and the monkey asthma model. Comparison of the effects of PRD-92-Ea and disodium cromoglycate.
    El-Azab J; Stewart PB
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):343-9. PubMed ID: 412794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical treatment of hay fever with disodium cromoglycate (DSCG) solution.
    Glazer I; Leventon G
    Int Arch Allergy Appl Immunol; 1975; 49(1-2):125-8. PubMed ID: 806539
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.
    Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indolo[2,1-c][1,4]benzodiazepines: a new class of antiallergic agents.
    Ho CY; Hageman WE; Persico FJ
    J Med Chem; 1986 Jun; 29(6):1118-21. PubMed ID: 2872333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Jun; 197(3):725-33. PubMed ID: 58988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of rat passive cutaneous anaphylaxis by 3-(tetrazol-5-yl)quinolines.
    Erickson EH; Hainline CF; Lenon LS; Matson CJ; Rice TK; Swingle KE; Van Winkle M
    J Med Chem; 1979 Jul; 22(7):816-23. PubMed ID: 109613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the anti-allergic effects of disodium baicalein 6-phosphate (BPS) and disodium cromoglycate (DSCG).
    Koda A; Watanabe S; Yanagihara Y; Nagai H; Sakamoto K
    Jpn J Pharmacol; 1977 Feb; 27(1):31-8. PubMed ID: 405519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. II. A comparison of the rat anti-dnp 7S 2 and rat reagin induced cutaneous reactions.
    Orr TS; Gwilliam J; Cox JS
    Immunology; 1971 Sep; 21(3):405-17. PubMed ID: 4998629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiallergic activity of alkyl substituted pyrazolo[3, 4-d]pyrimidine (compound 88-765).
    Gupta PP; Srimal RC; Avasthi K; Garg N; Chandra T; Bhakuni DS
    Indian J Exp Biol; 1995 Jan; 33(1):38-40. PubMed ID: 9135673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.